The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

about

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

Item

http://www.wikidata.org/entity/Q38215672

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

@en

type

Item

label

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

@en

prefLabel

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

@en

P1476

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

@en

P2093

Alì Taher

http://www.w3.org/2001/XMLSchema#string

Paolo Prandoni

http://www.w3.org/2001/XMLSchema#string

Raffaele Pesavento

http://www.w3.org/2001/XMLSchema#string

Sofia Barbar

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial

Oral rivaroxaban for symptomatic venous thromboembolism

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Idraparinux versus standard therapy for venous thromboembolic disease.

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Pulmonary embolism: risk assessment and management.

Clinical management of rivaroxaban-treated patients.

Practical management of rivaroxaban for the treatment of venous thromboembolism.

P2888

s11739-014-1085-4

P304

617-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-014-1085-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sally Temraz

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24871638

http://www.w3.org/2001/XMLSchema#string